Baxter Launches PERCLOT Absorbable Hemostatic Powder

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder ...

July 25, 2023 | Tuesday | News
Menarini Group Receives Positive CHMP Opinion for ORSERDU® in ER+ Metastatic Breast Cancer

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

July 24, 2023 | Monday | News
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for Catecholaminergic Polymorphic Ventricular Tachycardia Treatment

Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Lead molecule A...

July 21, 2023 | Friday | News
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $8 million in funding through a new grant program in the United States call...

July 21, 2023 | Friday | News
Integrated Biosciences Unveils Synthetic Biology Platform for Aging-Associated Stress Response Control

Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...

July 20, 2023 | Thursday | News
Junshi Biosciences' Toripalimab Accepted for First-line Treatment of Extensive-stage Small Cell Lung Cancer

According to data released by GLOBOCAN 2020, lung cancer is currently the most prevalent malignant tumor with the highest mortality rate in China. Small ce...

July 20, 2023 | Thursday | News
Neumora Therapeutics Begins Phase 3 Program for NMRA-140 in Major Depressive Disorder

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the planned init...

July 19, 2023 | Wednesday | News
Japan's ThinkCyte & FIMM Forge Research Partnership to Fight Blood Cancer

"Blood cancers are a complex, heterogeneous set of diseases and while the treatment landscape has advanced in recent years, there is still a lot we don't k...

July 18, 2023 | Tuesday | News
Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

 Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) r...

July 18, 2023 | Tuesday | News
Thermo Fisher Introduces Diomni Enterprise Software for Molecular Diagnostics

To address challenges with error-prone, manual molecular testing workflows, Thermo Fisher Scientific today has introduced Diomni Enterprise Software, helpi...

July 17, 2023 | Monday | News
GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US

GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in p...

July 14, 2023 | Friday | News
China's Regulatory Body Approves Shineco's Cardiac 5-Minute Test Marketing

Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of technologically advanced healthcare products and services, ...

July 11, 2023 | Tuesday | News
Axsome Therapeutics Initiates FOCUS Phase 3 Trial of Solriamfetol for Adult ADHD Treatment

FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter...

July 10, 2023 | Monday | News
Advanced FDA Cleared Magstim Horizon 3.0 TMS Now Available in United Kingdom

The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for sale in the UK, pr...

July 10, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close